Literature DB >> 16580263

Anti-endothelial cell antibodies from patients with limited cutaneous systemic sclerosis bind to centromeric protein B (CENP-B).

Amélie Servettaz1, Mathieu C Tamby, Philippe Guilpain, Joseph Reinbolt, Paloma Garcia de la Penã-Lefebvre, Yannick Allanore, André Kahan, Olivier Meyer, Loïc Guillevin, Luc Mouthon.   

Abstract

By using a quantitative immunoblotting technique on protein extracts of human macrovascular and microvascular endothelial cells, we have analyzed the self-reactive repertoires of IgG from 20 patients with limited cutaneous SSc, 40 patients with diffuse SSc and 60 age- and sex-matched healthy controls. Serum IgG from 15/20 patients with limited cutaneous SSc and anti-centromere antibodies bound to at least one of the two 75- and 85-kDa protein bands in the different endothelial cell extracts, whereas IgG from healthy controls or patients with diffuse SSc did not. N-terminal sequencing of the 75- and 85-kDa bands identified CENP-B as the sole antigen in both bands. Moreover, IgG from all of the SSc patients who recognized the 75- and/or 85-kDa bands bound to a full-length recombinant CENP-B protein as assessed by ELISA, whereas IgG from other SSc patients did not. The main target of anti-endothelial cell antibodies in patients with limited cutaneous SSc is the nuclear and ubiquitous protein CENP-B.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580263     DOI: 10.1016/j.clim.2006.02.006

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  13 in total

1.  Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis.

Authors:  Amélie Servettaz; Niloufar Kavian; Carole Nicco; Vanessa Deveaux; Christiane Chéreau; Andrew Wang; Andreas Zimmer; Sophie Lotersztajn; Bernard Weill; Frédéric Batteux
Journal:  Am J Pathol       Date:  2010-05-27       Impact factor: 4.307

Review 2.  Functional autoantibodies in systemic sclerosis pathogenesis.

Authors:  Angela Kill; Gabriela Riemekasten
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

3.  Anti-centromere antibody is an independent risk factor for chronic kidney disease in patients with primary biliary cirrhosis.

Authors:  Shintaro Mandai; Eiichiro Kanda; Yohei Arai; Suguru Hirasawa; Toshiyuki Hirai; Shota Aki; Naoto Inaba; Makoto Aoyagi; Hiroyuki Tanaka; Takaaki Ikeda; Teiichi Tamura; Sei Sasaki
Journal:  Clin Exp Nephrol       Date:  2012-12-26       Impact factor: 2.801

4.  Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.

Authors:  Chieh-Yu Shen; Ko-Jen Li; Pei-Hsuan Lai; Chia-Li Yu; Song-Chou Hsieh
Journal:  Clin Rheumatol       Date:  2017-09-23       Impact factor: 2.980

5.  Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis.

Authors:  A Servettaz; P Guilpain; C Goulvestre; C Chéreau; C Hercend; C Nicco; L Guillevin; B Weill; L Mouthon; F Batteux
Journal:  Ann Rheum Dis       Date:  2007-03-15       Impact factor: 19.103

Review 6.  Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases.

Authors:  Philippe Guilpain; Luc Mouthon
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 7.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

8.  Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis.

Authors:  Guillaume Bussone; Hanadi Dib; Mathieu C Tamby; Cedric Broussard; Christian Federici; Geneviève Woimant; Luc Camoin; Loïc Guillevin; Luc Mouthon
Journal:  Arthritis Res Ther       Date:  2011-05-13       Impact factor: 5.156

Review 9.  An innovative method to identify autoantigens expressed on the endothelial cell surface: serological identification system for autoantigens using a retroviral vector and flow cytometry (SARF).

Authors:  Tsuyoshi Shirai; Hiroshi Fujii; Masao Ono; Ryu Watanabe; Tomonori Ishii; Hideo Harigae
Journal:  Clin Dev Immunol       Date:  2013-01-16

10.  Autoantibodies recognizing the amino terminal 1-17 segment of CENP-A display unique specificities in systemic sclerosis.

Authors:  Elvira Favoino; Liboria Digiglio; Giovanna Cuomo; Isabella E Favia; Vito Racanelli; Gabriele Valentini; Federico Perosa
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.